课题基金 / 基金详情

Fabrication of a vascularized bioartificial pancreas using macroencapsulation of stem cell-derived pancreatic islet cells for the treatment of type 1 Diabetes.

Fabrication of a vascularized bioartificial pancreas using macroencapsulation of stem cell-derived pancreatic islet cells for the treatment of type 1 Diabetes.
使用干细胞来源的胰岛细胞的大封装制造血管化生物人工胰腺,用于治疗 1 型糖尿病。
批准号:
437123
负责人:
Brassard Jonathan
金额:
$10.93万
依托单位:
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-11-01 至 2023-11-01

项目摘要

项目成果

Brassard Jonathan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Type 1 diabetes affects more than 300 000 Canadians and its impact continues to rise in Canada and the world. Transplantation of pancreatic islets, the tissue regulating insulin and blood sugar, is a promising strategy to treat diabetic patients because i
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fabrication of a vascularized bioartificial pancreas using macroencapsulation of stem cell-derived pancreatic islet cells for the treatment of type 1 Diabetes
海外基金